After five years of operational presence on the market, medudoc is marking a clear turning point. November 2025 marks not only a change of ownership but also the start of a new phase of growth. An investor group led by the make visions family office has acquired the majority of shares – combined with additional capital and a clear mandate: to transform medudoc from a specialist provider of medico-legal patient education videos into a comprehensive platform for patient education, informed e-consent and legally sound workflow automation in everyday hospital work.
New chapter, new team, new brand identity
The change of ownership goes hand in hand with a strategic rebranding process. The blue previously used, which is widespread in the healthcare sector, gives way to a strong red – a deliberate signal of dynamism and determination. This clearly sets the medudoc brand apart from the competition.
At the same time, the management team has been expanded to drive the next phase of growth consistently. New on board:
- Martin Klässner (CEO)
- Lukas Bauer (CRO)
- Jerolim Filippi (CMO)
The founder Michael Horacek (Ambassador) and the previous managing director and founder Mona Ciotta (COO) remain operationally involved and ensure technological continuity and the medical-technical depth of the product.
From video provider to platform for the preoperative workflow
In terms of content, medudoc is realigning its strategy. The company is evolving from a producer of individualised medico-legal patient education videos into an end-to-end platform that:
- digitalises and standardises structured patient education,
- maps compliant informed consent (e-consent) entirely digitally,
- efficiently automates clinical legal and compliance workflows – such as documentation, risk notices, dealing with language barriers or preparing audits.
In this way, medudoc addresses key cost and compliance issues in everyday hospital work and positions itself as an end-to-end platform for legally sound, patient-centred communication.
Fresh capital for growth and expansion
With the entry of the new investors, the company receives additional capital. The funds go directly into product development, platform architecture, regulatory scalability and international market entry. The aim is to establish medudoc in digital patient education and electronic consent beyond the DACH region in the coming years.
Conclusion
The new medudoc is not simply a rebranding. It is a strategic fresh start, backed by additional capital, an expanded management team and a clear product vision. The new red stands for courage and a consistent focus on everyday hospital work.
